Director/PDMR Shareholding

10 May 2019

ARIX BIOSCIENCE PLC

Director/PDMR Shareholding

Arix Bioscience plc today announces the annual award of nil cost options to certain members of management, all of which are subject to performance conditions over a three year assessment period, in accordance with the company’s Remuneration Policy.

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Joseph Anderson
2	Reason for the notification
a)	Position / status	Chief Executive Officer
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP")
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	578,368
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	09 May 2019
f)	Place of the transaction	Outside a trading venue

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	James Hedley Rawlingson
2	Reason for the notification
a)	Position / status	Chief Financial Officer
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP")
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	234,239
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	09 May 2019
f)	Place of the transaction	Outside a trading venue

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Robert Lyne
2	Reason for the notification
a)	Position / status	Chief Operating Officer
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP")
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	195,199
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	09 May 2019
f)	Place of the transaction	Outside a trading venue

For further information:

Robert Lyne                        Chief Operating Officer                [phone]

 - Ends -